Latest news
Iconovo carries out a directed issue of shares of approx. SEK 25 million and a rights issue of shares of approx. SEK 24.6 million
The Board of Directors of Iconovo AB ("Iconovo" or the "Company") has today resolved on a directed share issue of approximately SEK 25 million (the…
Iconovo appoints Anders Månsson as new CEO
Iconovo AB (publ), a leader in the development of inhalable drugs based on proprietary inhalers and dry powder formulations, has today appointed Anders…
Press releases
Dec 17, 2018, 09:16
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Staff change
Nov 30, 2018, 09:15
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Nov 09, 2018, 08:45
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
Nov 08, 2018, 15:45
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Oct 31, 2018, 20:50
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Oct 30, 2018, 09:25
News
IR
Swedish
Corporate Information
Other Corporate Information
Oct 15, 2018, 09:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Aug 10, 2018, 09:00
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q2
Jul 03, 2018, 13:15
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
May 21, 2018, 09:15
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Staff change
May 16, 2018, 19:58
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Raport bolagsstämman
Apr 27, 2018, 09:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Staff change
Apr 23, 2018, 17:51
News
IR
Swedish
Corporate Information
Other Corporate Information
Apr 19, 2018, 08:00
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q1
Apr 18, 2018, 15:53
News
IR
Swedish
Corporate Information
Other Corporate Information
Apr 16, 2018, 08:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Apr 04, 2018, 09:05
News
IR
Swedish
Corporate Information
Other Corporate Information
Mar 26, 2018, 17:29
News
IR
Swedish
Corporate Information
Other Corporate Information
Mar 05, 2018, 16:42
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Action
Shares
Issuance
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 62 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
Interim CEO
Anders Månsson
Mail: anders.mansson@iconovo.se